REGENXBIO, Inc. (RGNX)

10.33 +0.07 (+0.68%) USD  |  NASDAQ  |  Feb 06, 16:00
10.30 -0.03 (-0.29%) After-Hours: 20:00
More

REGENXBIO Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Omeros Corp. Upgrade
Sarepta Therapeutics, Inc. Upgrade
AbbVie, Inc. Upgrade
CytomX Therapeutics, Inc. Upgrade
Krystal Biotech, Inc. Upgrade